Document Detail


Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study.
MedLine Citation:
PMID:  20570237     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To investigate outcomes after trabeculectomy using intraoperative intravitreal ranibizumab and topical mitomycin C (MMC) vs MMC alone. DESIGN: Prospective randomized single-site pilot study. METHODS: Patients diagnosed with primary open-angle glaucoma were randomized 1:1 to either combination intravitreal ranibizumab 0.5 mg and topically applied MMC (0.4 mg/mL for 2 min) or MMC (0.4 mg/mL for 2 min) therapy alone at time of trabeculectomy surgery. The primary endpoint measured was bleb morphology and vascularity using the Moorfields Bleb Grading System. Unqualified success was defined as postoperative intraocular pressure (IOP) of >5 and <22 mm Hg and a 30% decrease from baseline without use of postoperative hypotensive drops. Qualified success was defined as postoperative IOP of >5 and <22 mm Hg and a 30% decrease from baseline with use of postoperative hypotensive drops. RESULTS: Ten patients were randomized to either standard trabeculectomy with MMC (Group A) or trabeculectomy with intravitreal ranibizumab and MMC (Group B). All patients completed the study and were classified as unqualified successes. There were statistically significant differences in peripheral bleb area (P = .02), peripheral bleb vascularity (P = .02), and non-bleb-related peripheral conjunctiva vascularity (P = .0003), with Group B exhibiting more diffuse blebs with a lower degree of vascularity. CONCLUSIONS: Combination intravitreal ranibizumab and topical MMC at time of trabeculectomy resulted in more diffuse blebs with less vascularity when compared to use of topical MMC alone. Further studies are planned to better understand the utility of anti-vascular endothelial growth factor agents as modulators of wound healing post trabeculectomy.
Authors:
Malik Y Kahook
Related Documents :
6525577 - Sodium hyaluronate in trabeculectomy: a retrospective study.
19253237 - Adjunctive use of tafluprost with timolol provides additive effects for reduction of in...
20456437 - Comparative study of three prostaglandin analogues in the treatment of newly diagnosed ...
12065857 - Results of autografting of marginal conjunctiva in pterygium excision.
18480967 - Multilayer compression bandaging in the acute phase of deep-vein thrombosis has no effe...
23857507 - Telbivudine and adefovir combination therapy for patients with chronic lamivudine-resis...
Publication Detail:
Type:  Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2010-06-08
Journal Detail:
Title:  American journal of ophthalmology     Volume:  150     ISSN:  1879-1891     ISO Abbreviation:  Am. J. Ophthalmol.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-23     Completed Date:  2010-09-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370500     Medline TA:  Am J Ophthalmol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  399-403.e1     Citation Subset:  AIM; IM    
Copyright Information:
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Affiliation:
Department of Ophthalmology, University of Colorado Denver School of Medicine, Rocky Mountain Lions Eye Institute, 1675 Aurora Court, Aurora, CO 80045, USA. malik.kahook@gmail.com
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00661583
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Alkylating Agents / administration & dosage
Angiogenesis Inhibitors / administration & dosage
Antibodies, Monoclonal / administration & dosage*
Blister / pathology*
Cell Count
Combined Modality Therapy
Conjunctiva / blood supply*
Endothelium, Corneal / pathology
Glaucoma, Open-Angle / drug therapy*,  surgery*
Humans
Injections
Intraocular Pressure
Middle Aged
Mitomycin / administration & dosage*
Neovascularization, Pathologic / pathology
Pilot Projects
Prospective Studies
Trabeculectomy*
Treatment Outcome
Vitreous Body
Chemical
Reg. No./Substance:
0/Alkylating Agents; 0/Angiogenesis Inhibitors; 0/Antibodies, Monoclonal; 0/ranibizumab; 50-07-7/Mitomycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intraocular Pressure and Related Systemic and Ocular Biometric Factors in a Population-Based Study i...
Next Document:  Comparison of In Situ Excision and Whole-Globe Recovery of Corneal Tissue in a Large, Single Eye Ban...